Navigation Links
Marinus Pharmaceuticals, Inc. Announces Positive Results of its Phase 2 Clinical Trial of Ganaxolone as Adjunctive Therapy in Adults With Partial Onset Seizures
Date:3/2/2009

psy is a chronic neurologic condition that affects more than fifty million people worldwide and nearly three million people in the United States. Epilepsy is characterized by recurrent unprovoked seizures. Seizures can last from a few seconds to several minutes. They can have many symptoms, from convulsions and loss of consciousness to some that are not always recognized as seizures by the person experiencing them but by health care professionals: blank staring, lip smacking or jerking movements of arms and legs. One in 10 adults will have a seizure sometime during his or her life. Despite nearly ten new antiepileptic drugs being introduced over the past decade, 30 percent or close to one million people continue to have seizures even while taking two or more antiepileptic drugs.

    Contact:
    Shirley Chow
    Porter Novelli Life Sciences for Marinus Pharmaceuticals
    212-601-8308
    schow@pnlifesciences.com


'/>"/>
SOURCE Marinus Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Alseres Pharmaceuticals, Inc. Announces $200,000 Financing
2. Transdel Pharmaceuticals, Inc. Featured on National Broadcast Television
3. Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug
4. Angiotech Pharmaceuticals, Inc. - Notice of conference call and webcast
5. Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs
6. Transdel Pharmaceuticals, Inc. Retains FLP Pharma to Lead Business Development Activities
7. Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.
8. Genesis Pharmaceuticals Enters Into Agreement to Purchase Hongrui Pharmaceuticals, and Acquire 22 New Traditional Chinese Medicines
9. Renhuang Pharmaceuticals, Inc. Engages New Independent Auditor
10. Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements
11. Amira Pharmaceuticals, Inc. Expands its Scientific Advisory Board and Appoints Dr. Paul Anderson, Professor Jerold Chun and Professor Andrew Tager
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... New York, New York (PRWEB) September 02, 2014 ... metal-on-metal version of the DePuy Pinnacle hip implant ... jury selection begins today in the U.S. District ... reports. According to court documents, Johnson & Johnson ... 6,000 lawsuits that allege the all-metal hip caused ...
(Date:9/2/2014)... Raton, FL (PRWEB) September 02, 2014 ... audience targeting and multi-channel email marketing is pleased to ... the market, Firearms & Freedom as well ... online properties represent more than one million concerned Americans ... display advertising. , “We are honored to continue ...
(Date:9/2/2014)... research shows a novel polypill increases patient adherence ... heart attack, according to new study results reported ... 2014 in Barcelona, Spain. According to Principal Investigator ... Heart at Icahn School of Medicine at Mount ... de Investigaciones Cardiovasculares Carlos III (CNIC) in Madrid, ...
(Date:9/2/2014)... San Diego School of Medicine have identified an enzyme ... findings, reported in the current issue of PNAS, offer ... worldwide. An estimated 40,000 women in America will die ... Cancer Society. , "The take-home message of the study ... breast cancer metastasis through a pathway regulated by an ...
(Date:9/2/2014)... associated with many health risks, including heart disease and ... possible way to mitigate one often-overlooked risk: not buckling ... by Sheldon H. Jacobson, a professor of computer science ... are associated with a decrease in seatbelt usage. However, ... in effect. , "Primary seatbelt laws lead to increased ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Lawsuit Set For Trial in Federal Litigation, as Jury Selection Begins Today, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Lawsuit Set For Trial in Federal Litigation, as Jury Selection Begins Today, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Lawsuit Set For Trial in Federal Litigation, as Jury Selection Begins Today, Bernstein Liebhard LLP Reports 4Health News:ASG Continues to Bring New Lists to Market 2Health News:ASG Continues to Bring New Lists to Market 3Health News:New polypill increases heart attack patients' medication adherence 2Health News:New polypill increases heart attack patients' medication adherence 3Health News:Enzyme controlling metastasis of breast cancer identified 2Health News:Seatbelt laws encourage obese drivers to buckle up 2
... taken the National Polio Eradication Initiatives and now in ... Days (NIDs) have planned to immunize 22 million children ... ,Government of Bangladesh will carry out the initiatives ... (WHO), Rotary International and the U.S. Centers for Disease ...
... announced that, a novel treatment for brain tumors has ... as 'Oncophage' treatment, is aimed at tackling an aggressive ... of California, are at the helm of this research. ... from a portion of a patient's tumor. After breaking ...
... at least five times a year have more health problems ... ,And people with a severe gambling addiction are ... increased heart rate, angina and liver disease when compared to ... ,“One of the questions that has never been answered is ...
... women put on as they age, according to a finding ... doctor.//,In a study that followed more than 68,000 US women ... of Case Western Reserve University in Cleveland found that women ... weight during middle age. ,The findings were published in ...
... to the remedy of choice to treat chronic constipation.//A ... claims that, it is far more superior in effectiveness ... chronic constipation do not seem to offer the same ... disorder, affecting the intestinal tract .Today, its estimated that ...
... has found anti-clotting drug called bivalirudin (Angiomax) that beats ... coronary syndromes such as heart// attacks. This new blood ... from acute coronary syndromes. ,The Results of ... trial’ were published in November issue of the New ...
Cached Medicine News:Health News:Odds Are That Gamblers Have More Health Problems 2Health News:New Anti-Clotting Drug Less Risky For Heart Attack Patients 2
(Date:9/2/2014)... , Sept. 2, 2014  XBiotech announced ... study being conducted in the US for its ... Human™ monoclonal antibody therapy, is being evaluated in ... complicated with cachexia. The primary endpoint of the ... treated patients to a control population provided only ...
(Date:9/2/2014)...   Santa Clara dentist , Dr. Alan ... Invisalign. Invisalign is an orthodontic system that uses clear ... the orthodontic treatment of choice for older teens and ... For a limited time, patients can try Invisalign for ... usual cost. This offer cannot be combined, and some ...
(Date:9/2/2014)... , September 2, 2014 ... CONGRESS 2014 provide insight into treatment and outcomes ... clinical practice --   Data from ... Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF), an innovative, ... prevention strategies for atrial fibrillation (AF) patients remain ...
Breaking Medicine Technology:XBiotech Halts Study, Reports Positive Phase III Results with Antibody Therapy for Cancer 2Santa Clara Cosmetic Dentist, Dr. Alan Frame, is Now Offering a Special on Invisalign 2Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 2Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 3Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 4Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 5Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 6Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 7Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 8Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 9
... CANTEL MEDICAL CORP. (NYSE: CMN ) ... per diluted share, on a 24% increase in sales to a ... compares with net income of $4,274,000, or $0.25 per diluted share, ... 2010.  For the nine months ended April 30, 2011, the Company ...
... Pa., June 8, 2011 TetraLogic Pharmaceuticals, a biopharmaceutical ... treat cancer, today announced the appointment of Mr. Jonathan ... and vice president of corporate development. ... of corporate development and finance experience.  He has led ...
Cached Medicine Technology:Cantel Medical Reports 18% Increase in Net Income on 24% Increase in Sales 2Cantel Medical Reports 18% Increase in Net Income on 24% Increase in Sales 3Cantel Medical Reports 18% Increase in Net Income on 24% Increase in Sales 4Cantel Medical Reports 18% Increase in Net Income on 24% Increase in Sales 5TetraLogic Appoints Jonathan B. Lloyd Jones as Chief Financial Officer and Vice President Corporate Development 2
Livewire TC steerable ablation catheters are designed for the RF ablation of arrhythmias. They are available in a variety of curves and configurations, including bi-directional catheters for added fl...
Trilogy Pacemakers incorporates the clinically proven Omniscence™ accelerometer sensor with it's automatic alogorithms. The Trilogy family of pacemakers feature an array of products for bradyar...
... The Integrity ADx ... the world's smallest dual-chamber ... advanced pacemaker technology, including ... algorithm, the first U.S. ...
... Frontier II device is designed ... moderate to severe heart failure ... in patients who are symptomatic ... and who have prolonged QRS ...
Medicine Products: